ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

0.4695
-0.0282
(-5.67%)
Closed June 19 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.4695
Bid
0.469
Ask
0.47
Volume
2,516,778
0.4603 Day's Range 0.4967
0.4001 52 Week Range 1.11
Market Cap
Previous Close
0.4977
Open
0.482
Last Trade
100
@
0.4695
Last Trade Time
Financial Volume
$ 1,203,334
VWAP
0.478125
Average Volume (3m)
1,647,394
Shares Outstanding
1,189,970,308
Dividend Yield
-
PE Ratio
-8.69
Earnings Per Share (EPS)
-0.05
Revenue
1.93M
Net Profit
-64.37M

About Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is i... Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Northwest Biotherapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NWBO. The last closing price for Northwest Biotherapeutics (QB) was $0.50. Over the last year, Northwest Biotherapeutics (QB) shares have traded in a share price range of $ 0.4001 to $ 1.11.

Northwest Biotherapeutics (QB) currently has 1,189,970,308 shares outstanding. The market capitalization of Northwest Biotherapeutics (QB) is $559.29 million. Northwest Biotherapeutics (QB) has a price to earnings ratio (PE ratio) of -8.69.

NWBO Latest News

Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher

Imagine a new weapon in the fight against cancer, a personalized therapy that utilizes the body's own immune system to attack tumors. Science fiction? This biotech company just secured exclusive...

Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia

Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia   Miami, FL -- (InvestorsHub NewsWire – November 15, 2023) –...

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMTLComtech Telecommunications Corporation
$ 4.07
(87.56%)
91.43M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
ASNSActelis Networks Inc
$ 2.11
(83.48%)
51.37M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
LRHCLa Rosa Holdings Corporation
$ 1.78
(71.15%)
52.9M
STISolidion Technology Inc
$ 0.6881
(-64.35%)
16.36M
DMTKDermTech Inc
$ 0.1488
(-55.25%)
10.74M
QMCOQuantum Corporation
$ 0.3752
(-51.90%)
3.14M
ZNTLZentalis Pharmaceuticals Inc
$ 4.135
(-50.72%)
21.58M
AWINAERWINS Technologies Inc
$ 1.74
(-47.90%)
1.05M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
NVDANVIDIA Corporation
$ 135.58
(3.51%)
294.32M
MBIOMustang Bio Inc
$ 0.8517
(13.56%)
291.95M
CRKNCrown Electrokinetics Corporation
$ 0.0548
(-17.10%)
92.39M

NWBO Discussion

View Posts
dmb2 dmb2 12 minutes ago
dstock7734, thx much, it is so refreshing to see real DD posted about NWBO and in particular its medical science advancements. It makes so much sense to connect more of the groundbreaking work being conducted in the DC arena, which has so much broad promise for patients.

It is obvious where this endeavor is headed in the short term.

NWBO will spearhead the winning against the corrupt MM's. It is obvious our market system needs renewed checks and balances to restore integrity lost.
On the medical science front, NWBO is spearheading the efforts to advance what may (I think will) prove to be the ultimate front against cancer. There are obstacles still coming but the work here by NWBO is something to behold and the impending MHRA approval will be the turning point where the little engine that could has made it to the top.

GLTA
👍️0
Nemesis18 Nemesis18 57 minutes ago
>>>I would also be ok if they gave all 7 Market makers the gas chamber
👍️0
Doc logic Doc logic 2 hours ago
Chiugray,

Modifying the tumor microenvironment and systemic surveillance are what leads to a real cure because of prolonged immune memory. NWBO understands this very well and so do a few who have links to them. Direct modifies the tumor microenvironment all by itself but can also be enhanced even further than where it is at now to move towards the 100% cure rate potential that exists. This can happen when maximum specific activation for tumor type occurs. NWBO has been positioning itself to do exactly this and that’s why researchers from other companies and universities that are motivated to find a cure are willing to work with NWBO to be a part of that process. Some day Mr Market will wake up and see what many longs have seen for a very LONG time ; ). Best wishes.
👍️ 1
kabunushi kabunushi 3 hours ago
Thanks. I was interested to read what you had to say. Though I think the complaint says it all and lays it all out very clearly. Longs owe it to themselves to read it and understand exactly what is at issue. Management deserves decent compensation for what they manage to accomplish. In my student days long ago I was virulently anti-corporation-in-general but of course far from that after I became an investor. BUT, I sure as hell am anti "let's-give-all-the-ceos-as-many-boatloads-of-money-as-their-little-hearts-desire." Basically at that level of option grants, it's definitely taking money out of my pocket to give it to them. Longs need to stick up for their own interest, IMO. Tho sadly we know they won't.

WRT you recent opinion about the other action and the MTD: I have no legal expertise BUT I know who our lawyer is and I don't figure they would be wasting their time it they weren't pretty confident they could make the case so I'm just waiting and seeing. I wonder what expertise you have to make you so confident about second-guessing Laura and her firm. If and when they get past the MTD it's game on.

Laura H. Posner, a partner in the Securities Litigation & Investor Protection practice, has recovered billions on behalf of defrauded investors. Her cases include 6 of the top 100 securities fraud class action settlements of all time, including In re Wells Fargo, the 17th largest securities fraud recovery for investors ever. Laura has also been instrumental in successfully resolving for hundreds of millions of dollars and sweeping governance changes, groundbreaking derivative actions arising out of allegations of sexual misconduct and race discrimination, including obtaining the first ever, and to date only, demand futility decision in such a case.
👍️ 1
The Danish Dude The Danish Dude 3 hours ago
As Hoffmann has shown a long time ago, February 15th, the judge only granted the MTD on the loss of causation and wrote

"Magistrate Judge Stein gave $NWBO a roadmap to survive the MTD."

👨‍⚖️Judge Woods Motion to Dismiss Ruling👨‍⚖️$NWBO

The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.)

On February 14, 2024 Judge Woods granted Defendants’ Motion to Dismiss (“MTD”), with leave to amend. The Order can be found here:…— hoffmann6383 (@hoffmann6383) February 15, 2024

Sure did, and Laura Posner handed in 262 pages proving that.

In this follow up

➡️LOSS CAUSATION⬅️$NWBO

1. What is the Court looking for?

2. Will NWBO be able to provide the requested information?

The Case: https://t.co/SNKTxns1sw

1⃣The court is looking for a "formulaic connection between the referenced Pricing Dates and the sales price..." [1]…— hoffmann6383 (@hoffmann6383) February 15, 2024

Hoffmann wrote

Does $NWBO have information to show this formulaic connection?

In a January 12, 2024 NWBO filing entitled Plaintiff's Limited Objection to Magistrate Judge Stein's Report and Recommendation Regarding the Element of Loss Causation, $NWBO stated:

"While the Complaint does not reproduce the complete mathematical formula for each sale (which varies from sale to sale, so would require dozens of additional pages of allegations), it does specifically allege that this formula was monotonic in the closing price for each date. That is, the sale price generated by each of these formulas always decreased if the closing price of NWBO stock decreased on the indicated pricing date.

$NWBO's attorney infers that they are in possession of this information. I believe NWBO has this information available and we will see it filed within thirty days in $NWBO's Second Amended Complaint.

In this recent follow up

➡️NWBO's Memo in Opposition to Defendants' MTD⬅️

The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.)$NWBO has accused seven market makers of illegal share price manipulation.

Defendants: Canaccord Genuity LLC, Citadel Securities LLC,… pic.twitter.com/6hy6xrDZOZ— hoffmann6383 (@hoffmann6383) June 3, 2024

Hoffmann goes through the whole ordeal, in essence showing that defendants is on the shitter.

That you do not consider this ... well ... it actually isn't such a huge surprise considering your history 😅

Fud comes in many clothes and your disguise was uncloaked a long time ago, no matter how indifferent you wish to be about it.

MTD will be dismissed and market makers will be hammered by this lady

👍️ 3
Chiugray Chiugray 3 hours ago
Dstock, I don't know much about those connections or about how immune suppressors can be modulated by inhibitor drugs.

I can only speculate generally from a layman's perspective about this one thought. Using an inhibitor drug to modulate a naturally induced immune suppression (by-passing the immune system's checks and balances) would theoretically introduce some level of side effect. But if there are enhanced versions of DCs that can modulate the level of immune suppression via reprogramming the tumor microenvironment, then that changes everything. That means modulation without side effects. I have no idea if that is the case here, but if it was, then it would be profound.

The technologies include enhanced versions of dendritic cells (DCs) and DC based therapies, as well as conditioning regimens designed to enhance patient responses and approaches to reprogram the tumor microenvironment to boost immune therapies and help overcome resistance to checkpoint inhibitors. - 6/17/24 NWBO PR
👍️ 2
XMaster2023 XMaster2023 4 hours ago
Trying to mitigate the crime. I would also be ok if they gave all 7 Market makers the gas chamber.
👍️0
Poor Man - Poor Man - 5 hours ago
I never said spoofing is legal. What I said is what may look like spoofing to a novice is actually normal trading given how HFT functions (order, execute or cancel) within nanoseconds.
💩 1 🖕 1
XMaster2023 XMaster2023 5 hours ago
PM you have been drinking too much Kool-Aid. Spoofing is illegal. Not every trade is executed however the 5/10 manipulation upon what was good news. Was massive intensional spoofing. If Martha Stuart can go to jail for insider trading the 7 Market Makers can go to jail for spoofing a future cure to cancer. Don’t worry the jury will let the rich guys go. NOT! Most longs would give them the chair.
👍️ 2
Poor Man - Poor Man - 5 hours ago
The feeling is mutual, but glad we typically ignore each other. I do owe you a response about the proxy vote.

I want to think about it for another day or two.

don't like PM much (I think he's long but I'm not even sure of that and I mostly ignore him as a matter of personal taste)

👍️0
kabunushi kabunushi 5 hours ago
"SIO can keep loading on the open market if SIO is really serious".
Why the hell would they do that instead of negotiating deals for capital infusion at a discount to market, because NW needs the fracking capital? Besides this, NWBO desperately needs continuing cash infusions so why the hell would a very supportive hedge fund not inject their cash into the company instead of the open market when investing? You show no understanding at all of the way the capital markets work.

By the way, you still owe me a big apology for suggesting that I fronted a post ghost written by PM. That was incredibly stupid. Before you insult a fellow long like that why the hell don't you check out some of their other posts to understand which side they are on? I don't like PM much (I think he's long but I'm not even sure of that and I mostly ignore him as a matter of personal taste) but I happen to agree with him on the excessive nature of the executive compensation of the true-up option grants. Being long doesn't mean you have to get a lobotomy and stop exercising your own judgment. Some of you guys here need to learn that.

This MB is sickeningly polarized and we all know who the very bad guys are but the whole thing is made worse by longs who fail to discern anything besides pure white and pure black. Longs should be able to discuss their disagreement with management here. Fellow longs need to be able to tolerate a little bit of ambiguity in other posters' attitudes without automatically acting like crazy pit bulls toward any comment that fails to kiss management's collective asses to their liking.

Among longs some know a lot, and others don't know too much. Some of the most rabid of the longs seem to be among the latter group. And they don't help this MB to be the best valuable communication tool for people who are already or potential investors in NW.
👍️ 2 💯 2
Poor Man - Poor Man - 5 hours ago
I will save this post of yours for when the MTD is granted. I’ll file it under all the others assertions you make that never come to fruition. It’s very difficult to show loss causation when a stock is traded OTC and there are other factors at work, such as the constant dilution of the share count. That’s what came through in the responses.

Not every trade is executed even via HFT, so what looks like spoofing to you is just a normal function of those platforms. You really don’t understand how HFT works in the real world. Series 63, big shit.
💩 1 🖕 1
biosectinvestor biosectinvestor 5 hours ago
There has been plenty of news, and that suggests more news ahead and significant news. The chatter with shorts constantly posting and more than usual suggests rather that they are afraid, given the validating news most recently.
👍️ 3
CrashOverride CrashOverride 5 hours ago
Every prop trader or market maker works in high frequency as latency on the wire means lost arbitrage. There's no reward for being last. You really are grasping at straws, daily.

MTD has already been passed on all elements except loss causation which the judge said would be met if forumula was provided which it was in the amended complaint.

SDNY takes its role as the most important regulator of Wall Street seriously. We will soon see that reputation upheld.
👍️ 2
brooktrail1933 brooktrail1933 6 hours ago
I think you have the wrong poster.
👍️0
Margin Buu Margin Buu 6 hours ago
It’s highly probable after Cohen Milstein submits the amendment that the Motion to Dismiss is denied and then this goes to discovery. Have fun with that 😘

Here is the chronology of the lawsuit:

December 1, 2022 NWBO filed the lawsuit. It is being represented by the highly respected Cohen Milstein law firm.
April 10, 2023 NWBO filed the First Amended Complaint
July 12, 2023 Defendants responded with a Motion to Dismiss (MTD).
November 14, 2023 Oral arguments from plaintiff and defendants were heard.
December 29, 2023 Magistrate Judge Stein oversaw this opening phase of the law suit and issued an extensive 85 page Report and Recommendation (R&R) summarizing his findings.
February 14, 2024 District Judge Woods agreed with and adopted the R&R. The R&R was overall very favorable to NWBO. It concluded that the market makers through spoofing on numerous occasions had purposely manipulated the price of NWBO to cause it to decline. Judge Woods also adopted Judge Stein’s position that NWBO had not sufficiently pled loss causation and on that basis granted the Defendants’ MTD.
Importantly, the Court allowed leave to amend the complaint on the sole issue of loss causation emphasizing that such an amendment would not be futile. In the R&R, the Court laid out a clear roadmap on how NWBO could successfully address loss causation in which case the MTD would be denied and NWBO could proceed to discovery. This Second Amended Complaint is due on, or before March 15, 2024.
🏆️ 1 👍️ 4
ilovetech ilovetech 7 hours ago
Are you implying that these institutions are actually committed to getting to the bottom of the crimes being committed?
If they can’t event get past that in a civil case, what makes you think that SEC and DOJ will ever have sufficient evidence to bring a criminal case for spoofing against those same market makers
👍️ 3
dstock07734 dstock07734 7 hours ago
I am not sure if SIO takes on the role of being supportive or if SIO sees a great investment opportunity. Assuming it is latter, then I suspect LP didn't give SIO C-share option and the maximum number LP can offer is 8m. SIO can keep loading on the open market if SIO is really serious.

Last quarter SIO invested in a company developing FGFR inhibitors to modulate immunosuppression from Treg Cells. Pawel Kalinski can provide solution on tacking immunosuppression from MDSCs. Plx3397 can overcome immunosuppression due to TAMs. Is that interesting?
👍️ 1
Chiugray Chiugray 7 hours ago
The point I take from this is that SIO Capital Management can and does take on the role of being a supportive financial investor, ie taking on a significant ownership % in a single company. That is important.
🏆️ 2 👍️ 5
Poor Man - Poor Man - 8 hours ago
The market makers already had one MTD granted that required NWBO to amend their complaint. And counsel’s arguments that NWBO can’t show loss causation are very convincing.

I would say Drop the Mic convincing,
🐀 1 👺 1
Margin Buu Margin Buu 8 hours ago
“Having difficultly”? No, they’re not. You suspect the MTD is granted based on this false notion? lol keep trying poor man.

the Court allowed leave to amend the complaint on the sole issue of loss causation emphasizing that such an amendment would not be futile. In the R&R, the Court laid out a clear roadmap on how NWBO could successfully address loss causation in which case the MTD would be denied and NWBO could proceed to discovery. This Second Amended Complaint is due on, or before March 15, 2024.
https://smithonstocks.com/denial-of-the-motion-to-dismiss-in-northwest-biotherapeutics-lawsuit-against-seven-wall-street-market-makers-for-spoofing-would-be-a-major-catalyst-for-the-company/
🏆️ 2 👍️ 3
drugrunner drugrunner 8 hours ago
I guess your are on the side of the paid BASHERS
🏆️ 1 👍️ 1 💩 1 🤡 1
KevGee59 KevGee59 8 hours ago
Just got a call from someone in NY that wanted me to vote my shares. I haven't done so yet. When I told her I'll vote my shares myself later, she said she could take my vote right now. I declined and and told her I still had a week. She was a little persistent...lol.

First time I've ever got a call to vote my shares...
👍️0
dstock07734 dstock07734 8 hours ago
Dr. Kalinski's NIH grants.

Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
https://reporter.nih.gov/search/Iq7W4FhuI02dP0i2t5LCtg/project-details/10362635

Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
https://reporter.nih.gov/search/Iq7W4FhuI02dP0i2t5LCtg/project-details/10362700

Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
https://reporter.nih.gov/search/_uivwg8M9U6kGGPuEz-kMQ/project-details/10689822
🏆️ 1 👍️ 4
RobotDroid RobotDroid 8 hours ago
As I see the insults fly back and forth, I'm getting the sinking feeling that there will be zero news between now and the ASM. That will result in a short meeting to count the already rigged votes, answer a few preselected questions while ignoring the hard, pertinant ones, and a shareprice disaster flowing into July and the Fall. Since they cannot know when the approval will come, the ASM is simply to close the vote for the money grab in their favor, tout what is already known as exciting and promising (which it is but irrelevant to the sinking share price), and not address the painful concerns of the suffering retail shareholders. So if you want a cookie and a soda and soft peddling of great things to come in an unknowable future and rub elbows with the rich getting richer, than by all means show up and kiss the ring. This should have been done years ago but due to horrible non management and inept execution, here we are in limbo years later. The only people getting rewarded are mismanagement, and the peon shareholders can stand around and guess what month and what year we may get UK approval while also guessing on various submissions to the FDA, etc in 2025 or beyond. Set your expectations very low as many will be disappointed by what does not transpire in the week and months to come. You may hate my words, but I bet this all is the truth. Someday the approvals will come, but it ain't today, tomorrow, next week or next month. The rich are going to get richer, the backbone of the company, us poor shareholders, are going to still be waiting on Gadot.
🐀 1 👍️ 1 👺 1
theorysuit theorysuit 8 hours ago
when you can't explain the downward spiral of your price because your management is bending you over.... you cry FUD or paid basher. Sorry brother, you management is the one bending you over. Seriously drugrunner you gotta come up with a new excuse now.
🎯 1 🐀 1 👍️ 3 👺 1
Homebrew Homebrew 8 hours ago
Time for new material. That joke's about 50 years old by now...sigh....
...paying you to bash...
👺 1
Foogie88 Foogie88 8 hours ago
Why don’t you go to sleep, eat or anything other than posting on this board 24/7? You have got to have kids that post in your place. No way somebody can stay on a board 24/7 everyday!
👍️ 1 💀 1 💩 1 💲 1 💵 1 🤡 1 🤣 1
dstock07734 dstock07734 8 hours ago
Dr. Pawel Kalinski had $14.5M grant from NCI. According to the article, OmniSeq Inc is the company which will conduct molecular testing. The interesting part is that OmniSeq was acquired by a company called Labcorp in July 2021. SIO opened a position on Labcorp in May 2022 and held the small position for only short period of time. Then starting August 2023, SIO has been accumulating Labcorp shares and until the filing of the last quarter, Labcorp is the largest one in SIO's portfolio accounting for almost 15%. Is it just a coincidence?

OmniSeq Inc. will conduct advanced molecular diagnostic testing on participating patients’ tumor cells as part of the studies. AIM ImmunoTech Inc. has agreed to provide rintatolimod (brand name Ampligen), the chemokine-modulating agent to be incorporated into these studies.

https://www.onclive.com/view/roswell-parks-dr-pawel-kalinski-to-lead-145m-ncifunded-immunotherapy-effort

Labcorp expands oncology portfolio with OmniSeq® acquisition.
https://oncology.labcorp.com/cancer-care-team/news-events/labcorp-expands-oncology-portfolio-omniseqr-acquisition

👍️ 4 🚀 1
Poor Man - Poor Man - 8 hours ago
This company is having difficulty get past the MTD for the spoofing case, which I now suspect will be granted. If they can’t event get past that in a civil case, what makes you think that SEC and DOJ will ever have sufficient evidence to bring a criminal case for spoofing against those same market makers?

The underlying problem with the market makers is HFT. But that’s a different subject, albeit related.
🐀 3 👺 2 💩 2 🖕 1
Idunno Idunno 9 hours ago
Thank you. I do know better. It appears to me the attempts to crush n capture this company will fail. Now, when that’s, cemented, let’s try and get some Justice. You know why? Because it’s the right thing to do.
🏆️ 1 👍️ 5 💯 1
Poor Man - Poor Man - 9 hours ago
I’m amazed by it.

I don’t think we’re doomed as a country per se.
🐀 2 👺 1 💩 1
Poor Man - Poor Man - 9 hours ago
Really?

Read the proxy and Judge Laster’s comments. And tell me if he’s victim blaming?

You should know better.
🐀 2 👺 1 💩 2 🖕 1
learningcurve2020 learningcurve2020 9 hours ago
They don't understand that and that's the problem! I think the country is doomed.
🐀 2 👺 1 💩 1 🖕 1 🤮 1
Idunno Idunno 9 hours ago
Oh. Let’s hold those committing crimes responsible. And, as you well know, I’m not talking about management. That reeks of victim blaming. Maybe that’s why you got pooped on. Something smelled?
👍️ 3 💯 1
Zadie420 Zadie420 9 hours ago
Yes. All corrupt.
🏆️ 1 👍️ 1
dennisdave dennisdave 9 hours ago
Get lost yourself penniless clown
🐀 1 👺 1 🤢 1 🤮 1
dennisdave dennisdave 9 hours ago
You are known here as a DCVAX basher
You have repeatedly stated that DCVAX L does not work and will not be approved. Short soon you will be financially ruined.
🐀 1 👺 1 🤢 1 🤮 1
dennisdave dennisdave 9 hours ago
Laughable circus zealot psychopath.

Touting the comparison of DCVax Direct to grapefruit juice by you makes you a huge basher of DCVAX.

So you hate DCVAX but worship management circus clown.
🐀 1 👺 1 🤢 1 🤮 1
dennisdave dennisdave 9 hours ago
as if you are consulting other posters here about any other poster. Double your dose of ani psychotics
🐀 1 👺 1 🤢 1 🤮 1
polska polska 9 hours ago
You saw blatant manipulation with GME and AMC, and nothing was done. CDEL mismarked orders for ~10 years and the SEC gives them a 7 million dollar fine. Are the regulators part of the problem?
🎯 1 👍️ 2
Poor Man - Poor Man - 9 hours ago
Of course a post that encourages accountability is pooped on.

Not surprised.
🐀 2 👺 1 💩 2 🖕 1
learningcurve2020 learningcurve2020 9 hours ago
"Means nothing. Never question."

-The disciples way.
🐀 2 👺 1 👿 1
learningcurve2020 learningcurve2020 9 hours ago
"We don't care"

-The disciples.
🐀 2 👺 1 👿 1
Poor Man - Poor Man - 9 hours ago
As you know Idunknow, when management is held accountable, you improve the odds for better outcomes in the future.
🐀 2 👍️ 3 👺 1 💩 1 🖕 2 🤡 3
learningcurve2020 learningcurve2020 9 hours ago
See no evil.
🐀 2 👺 1 👿 1
learningcurve2020 learningcurve2020 9 hours ago
WE ARE UNITED AND WE DO NOT CARE!!!

...It's the disciples way.
🐀 2 👺 1 👿 1
learningcurve2020 learningcurve2020 9 hours ago
Too practical.
🐀 2 👺 1 👿 1
learningcurve2020 learningcurve2020 9 hours ago
Shrugs turned into a disciple sort of dance.
🐀 2 👺 1 👿 1
Doc logic Doc logic 9 hours ago
Lefty49,

Thanks for checking in. Looking forward to the next leg in the NWBO journey with you along with all true longs. Blessings and best wishes.
👍️ 2